Functional differences in mesenchymal stromal cells from human dental pulp and periodontal ligament

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 2, 2014, Pages 344-354

  Vasandan, Anoop Babu ^a   Shankar, Shilpa Rani ^a   Prasad, Priya ^a   Sowmya Jahnavi, Vulugundam ^a   Bhonde, Ramesh Ramachandra ^a   Jyothi Prasanna, Susarla ^a  

^a MANIPAL UNIVERSITY   (India)

Author keywords

Dental pulp stromal cells; Differentiation; Immune properties; Mesenchymal stromal cells; Periodontal ligament stromal cells; Pro inflammatory cytokines; Stem cells

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 4; STAGE-SPECIFIC EMBRYONIC ANTIGEN-4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANTIBODY SPECIFICITY; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DENTAL PULP STROMAL CELLS; DIFFERENTIATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNE PROPERTIES; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOCYTE; PERIODONTAL LIGAMENT; PERIODONTAL LIGAMENT STROMAL CELLS; PRO-INFLAMMATORY CYTOKINES; STEM CELL; TOOTH PULP;

DENTAL PULP STROMAL CELLS; DIFFERENTIATION; IMMUNE PROPERTIES; MESENCHYMAL STROMAL CELLS; PERIODONTAL LIGAMENT STROMAL CELLS; PRO-INFLAMMATORY CYTOKINES; STEM CELLS;

ADIPOCYTES; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; DENTAL PULP; GENE EXPRESSION; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; MESENCHYMAL STROMAL CELLS; ORGAN SPECIFICITY; OSTEOCYTES; PERIODONTAL LIGAMENT; STAGE-SPECIFIC EMBRYONIC ANTIGENS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893656763     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12192     Document Type: Article

References (34)

1. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
2. Chang YJ, Shih DT, Tseng CP, et al. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells. 2006; 24: 679-85.
3. Hsieh JY, Fu YS, Chang SJ, et al. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev. 2010; 19: 1895-1910.
4. Strioga M, Viswanathan S, Darinskas A, et al. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived Mesenchymal stem and stromal cells. Stem Cells Dev. 2012; 21: 2724-52.
5. Al-Nbaheen M, Vishnubalaji R, Ali D, et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev. 2013; 9: 32-43.
6. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res. 2009; 88: 792-806.
7. Rodríguez-Lozano FJ, Insausti CL, Iniesta F, et al. Mesenchymal dental stem cells in regenerative dentistry. Med Oral Patol Oral Cir Bucal. 2012; 17: 1062-67.
8. Tolar J, Le Blanc K, Keating A, et al. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells. 2010; 28: 1446-55.
9. English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol. 2013; 91: 19-26.
10. Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2: 141-50.
11. Prasanna SJ, Gopalakrishnan D, Shankar SR, et al. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS ONE. 2010; 5: 9016.
12. Wu KH, Tsai C, Wu HP, et al. Human application of ex-vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation. Cell Transplant. 2013; 22: 2041-51.
13. Wu KH, Sheu JN, Wu HP, et al. Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study. Transplantation. 2013; 95: 773-7.
14. Baksh D, Davies JE, Zandstra PW. Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. Blood. 2005; 106: 3012-9.
15. Mafi P, Indocha S, Mafi R, et al. Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature. Open Orthop J. 2011; 5: 253-60.
16. Ali JM, Bolton EM, Bradley JA, et al. Allorecognition pathways in transplant rejection and tolerance. Transplantation. 2013; 96: 681-88.
17. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105: 1815-22.
18. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res. 2006; 312: 2169-79.
19. Akiyama K, Chen C, Wang D, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012; 10: 544-55.
20. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002; 99: 3838-43.
21. Rasmusson I, Ringdén O, Sundberg B, et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res. 2005; 305: 33-41.
22. Silvério KG, Rodrigues TL, Coletta RD, et al. Mesenchymal stem cell properties of periodontal ligament cells from deciduous and permanent teeth. J Periodontol. 2010; 81: 1207-15.
23. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet. 2004; 364: 149-55.
24. Zhang W, Walboomers XF, Shi S, et al. Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation. Tissue Eng. 2006; 12: 2813-23.
25. Sonoyama W, Liu Y, Yamaza T, et al. Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod. 2008; 34: 166-71.
26. Hilkens P, Gervois P, Fanton Y, et al. Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells. Cell Tissue Res. 2013; 353: 65-78.
27. Miura M, Gronthos S, Zhao M, et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci. 2003; 100: 5807-12.
28. Osathanon T, Manokawinchoke J, Nowwarote N, et al. Notch signaling is involved in neurogenic commitment of human periodontal ligament-derived mesenchymal stem cells. Stem Cells Dev. 2013; 22: 1220-31.
29. Carinci F, Papaccio G, Laino G, et al. Comparison between genetic portraits of osteoblasts derived from primary cultures and osteoblasts obtained from human pulpar stem cells. J Craniofac Surg. 2008; 19: 616-25.
30. Polchert D, Sobinsky J, Douglas G, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol. 2008; 38: 1745-55.
31. Sarugaser R, Hanoun L, Keating A, et al. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS ONE. 2009; 4: 6498.
32. Blasi A, Martino C, Balducci L, et al. Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vasc Cell. 3: 5.
33. Banas A, Teratani T, Yamamoto Y, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007; 46: 219-28.
34. Magatti M, De Munari S, Vertua E, et al. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells. 2008; 26: 182-92.